Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
General Capital (GEN) / HY23

PBT up 390.8% on 94.7% revenue growth as margin reached 43.5%

Operating leverage from a fast-scaling loan book quintupled PBT in a still-small finance company increasingly funded by term deposits.

Financials / Finance company

GEN revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $12.9m, versus $22.6m in FY25.

GEN operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was $2.8m, versus $41.4b in FY25.

GEN NPAT trajectory

Statutory profit after tax across covered periods.

↗
Loading chart...
HY26 was $1m, versus $2.8m in FY25.

GEN net debt

Borrowings less cash across covered periods.

↗
Loading chart...
FY25 was $148.7m, versus $85.3m in HY25.
Release date
29 November 2022
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY23 vs HY22

Revenue

$3.5m

+94.7% ↑ vs $1.8m

Net profit after tax

$1m

+100.3% ↑ vs −$357.4m

Net cash inflow from operating activities

$2.6m

— vs —

Profit before tax

$1.5m

+100.3% ↑ vs −$529.7m

Cash and cash equivalents

$17.2m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Total assets

$126.3m

+52.7% ↑ vs $82.7m

What changed

Revenue grew 94.7% to NZ$3.5m and PBT jumped 390.8% to NZ$1.5m — materially above Annolyse's historical baseline mean for PBT growth across subsequent interim periods

NPAT grew 390.6% to NZ$1.0m. PBT margin reached 43.5%, well above the supplied historical baseline mean of 10.6%, signalling that operating leverage scaled hard as the lending book grew. Total assets rose 52.7% to NZ$126.3m and total liabilities rose 54.6%, with the asset growth funded predominantly by term deposit gathering. Cash improved to NZ$17.2m from NZ$15.1m, and operating cash flow came in at NZ$2.6m with capex effectively nil.

What matters

Operating leverage was the central story

Revenue near-doubled but profits more than quintupled, lifting PBT margin to 43.5% against a historical baseline mean of 10.6%. This matters because it tells you the marginal economics of the loan book are dropping a much larger share of incremental revenue to profit at current scale — the open question is whether that margin holds as competition for both loans and deposits intensifies at higher asset levels.

Growth is deposit-funded, not equity-funded. Liabilities up 54.6% versus equity up 39.8% means the company is scaling the lending book by gathering more term deposits, which is the standard finance-company model but concentrates the strategic question on funding cost trajectory and asset quality rather than headline profit growth.

Credit rating outlook strengthened. Commentary references General Finance's BB- rating moving to a Positive outlook, attributed to growth and margin gains. This matters because it directly affects the cost of attracting the term deposits funding the asset book.

Expectations

The guidance commentary in the release pointed to total assets of NZ$120-125m and term deposits of NZ$105-110m by 30 September; reported total assets of NZ$126.3m landed slightly above the guided range

Management also flagged an expected record September monthly profit. No formal full-year earnings target is supplied. The prior-period second-half shape is not informative for forecasting because HY22 was on a very different earnings trajectory, so what this release supports is that the lending book is scaling broadly in line with the commentary, not that a specific FY23 outcome is anchored.

Quality of result

The 0.2 percentage-point gap between PBT growth (+390.8%) and NPAT growth (+390.6%) means tax did not distort the headline — the effective tax rate at around 32.5% is essentially unchanged versus the prior comparable, though it sits above Annolyse's historical baseline mean for the metric, which is closer to zero across later periods

Free cash flow of NZ$2.6m actually exceeded NPAT (FCF/NPAT 246.4%), reflecting effectively nil capex (0.0% of revenue) and a negligible trade receivables balance.

On an absolute basis, pre-lease FCF of NZ$2.6m sits below the supplied historical baseline mean of NZ$9.3m — but that baseline draws on later, larger-scale periods, so the read is "smaller in absolute terms" rather than weak conversion. The result looks durable on operating quality: margin expansion is real, working capital is tightly managed, and capex is immaterial. The principal quality caveat is scale: the percentage gains come off a small profit base, so a modest dollar movement in either direction will continue to produce large reported growth rates.

Unresolved

Open questions

What was the period-on-period growth in the net loan receivables book, and how is it split by lending category and credit grade?
How are blended term-deposit funding costs trending, and what net interest margin does the 43.5% PBT margin imply on a run-rate basis?
Why does the effective tax rate sit above the 28% NZ corporate rate, and should investors expect that to persist for the full year?
Will the record September monthly profit referenced in commentary translate into a materially stepped-up second half, or is HY23 already capturing a peak margin level?
How does management see competition for both lending and deposit gathering evolving in the BB- credit tier over the next 12 months?

This briefing cannot assess loan-book credit quality, asset-liability duration matching, or net interest margin without further disclosure of those underlying metrics.

Chat

Ask about GEN HY23

Ask follow-up questions about General Capital's HY23 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about GEN HY23

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about General Capital's HY23 result.

What was the period-on-period growth in the net loan receivables book, and how is it split by lending category and credit grade?Why does "Operating leverage was the central story" matter?How strong was the cash and earnings quality in HY23?What should I watch next for GEN after HY23?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Half Year Results Announcement - 30 September 2022

HY23 / financial report↗

Prior comparable period

Half Year Results Announcement - 30 September 2021

HY22 / financial report↗

Full-year context

General Capital Limited (GEN.NZ) Annual Report - 31 March 2022

FY22 / financial report↗

Release context

2022 Annual Meeting - Presentation Slides

HY23 / commentary↗

General Capital Annual Meeting Results and Update - 28092022

HY23 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Revenue growth context

Revenue growth was 94.7% for this reporting period.

→

ROE and capital efficiency

ROE was 7.1%, +10.6pp versus the prior comparable period.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 0.2pp.

→

Working-capital pressure

Debtor days were 0 days for this result.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when GEN publishes next

Get the next General Capital briefing and related NZX reporting-season updates by email.